2023 - Improving Study and CRO Oversight Plan through BIMO Findings

Discover a groundbreaking webinar delving into the untapped potential of the Food and Drug Administration’s (FDA) bioresearch monitoring (BIMO) metrics. Over two decades, the results of BIMO inspection findings have remained stagnant. This webinar ventures beyond the surface, revealing their transformative potential in shaping your contract research organization’s (CRO) oversight strategy.
The featured speakers will explore how different monitoring methods will result in different trial quality findings — what they identify and what they don’t. The discussion will detail approaches that enable study teams to meet good clinical practices (GCP) requirements, achieve optimal trial quality and ensure human subject protection.
Join this webinar as the featured speakers put real-world data to work and demonstrate how it can directly enhance CRO oversight. In just one engaging session, unlock risk-based innovation and upgrade the approach to clinical trial management through the underexplored potential of BIMO metrics.